Search research articles
Contact Us
Filters
Showing results (891-900 of 988) with videos related to
Page
of 99
Sort By:
American Heart Journal
|
February 18, 2024
Variation in risk-adjusted cardiac intensive care unit (CICU) length of stay and the association with in-hospital mortality: An analysis from the Critical Care Cardiology Trials Network (CCCTN) registry
Daniel M Koerber, Jason N Katz, Erin Bohula, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 12, 2021
Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory Cancer
Seung Tae Kim, Simon A Smith, Peter Mortimer, et al.
British Journal of Cancer
|
November 3, 2018
pRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry
Gemma N Jones, Claire Rooney, Nicola Griffin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2024
CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive Tumors
Sophie Archer, Phillip M Brailey, Minjung Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 2021
Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in Combination with Carboplatin in Patients with Advanced Solid Tumors: A Phase I Study
Timothy A Yap, Matthew G Krebs, Sophie Postel-Vinay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2020
Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline
Nadine M Tung, Judy C Boughey, Lori J Pierce, et al.
JCO Oncology Practice
|
January 11, 2023
Increasing Racial and Ethnic Equity, Diversity, and Inclusion in Cancer Treatment Trials: Evaluation of an ASCO-Association of Community Cancer Centers Site Self-Assessment
Carmen Guerra, Alice Pressman, Patricia Hurley, et al.
Thorax
|
December 13, 2018
Positive airway pressure for sleep-disordered breathing in acute quadriplegia: a randomised controlled trial
David J Berlowitz, Rachel Schembri, Marnie Graco, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 9, 2008
NCCN Task Force Report: breast cancer in the older woman
Robert W Carlson, Susan Moench, Arti Hurria, et al.
British Journal of Cancer
|
October 19, 2021
Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response
Sophie E Willis, Claudia Winkler, Martine P Roudier, et al.
Page
of 99
Search research articles
Search
Showing results (891-900 of 988) with videos related to
Sort By:
Page
of 99
American Heart Journal
|
February 18, 2024
Variation in risk-adjusted cardiac intensive care unit (CICU) length of stay and the association with in-hospital mortality: An analysis from the Critical Care Cardiology Trials Network (CCCTN) registry
Daniel M Koerber, Jason N Katz, Erin Bohula, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 12, 2021
Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory Cancer
Seung Tae Kim, Simon A Smith, Peter Mortimer, et al.
British Journal of Cancer
|
November 3, 2018
pRAD50: a novel and clinically applicable pharmacodynamic biomarker of both ATM and ATR inhibition identified using mass spectrometry and immunohistochemistry
Gemma N Jones, Claire Rooney, Nicola Griffin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2024
CB307: A Dual Targeting Costimulatory Humabody VH Therapeutic for Treating PSMA-Positive Tumors
Sophie Archer, Phillip M Brailey, Minjung Song, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 24, 2021
Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in Combination with Carboplatin in Patients with Advanced Solid Tumors: A Phase I Study
Timothy A Yap, Matthew G Krebs, Sophie Postel-Vinay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2020
Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline
Nadine M Tung, Judy C Boughey, Lori J Pierce, et al.
JCO Oncology Practice
|
January 11, 2023
Increasing Racial and Ethnic Equity, Diversity, and Inclusion in Cancer Treatment Trials: Evaluation of an ASCO-Association of Community Cancer Centers Site Self-Assessment
Carmen Guerra, Alice Pressman, Patricia Hurley, et al.
Thorax
|
December 13, 2018
Positive airway pressure for sleep-disordered breathing in acute quadriplegia: a randomised controlled trial
David J Berlowitz, Rachel Schembri, Marnie Graco, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 9, 2008
NCCN Task Force Report: breast cancer in the older woman
Robert W Carlson, Susan Moench, Arti Hurria, et al.
British Journal of Cancer
|
October 19, 2021
Retrospective analysis of Schlafen11 (SLFN11) to predict the outcomes to therapies affecting the DNA damage response
Sophie E Willis, Claudia Winkler, Martine P Roudier, et al.
Page
of 99